Rezultati - Sanjeev Phatak

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Antibody response after first and second-dose of ChAdOx1-nCOV (CovishieldTM®) and BBV-152 (CovaxinTM®) among health care workers in India: The final results of cross-sectional coronavirus vaccine-induced antibody titre (COVAT) study

    Antibody response after first and second-dose of ChAdOx1-nCOV (CovishieldTM®) and BBV-152 (CovaxinTM®) among health care workers in India: The final results of cross-sectional coro... od Awadhesh Kumar Singh, Sanjeev Phatak, Ritu Singh, Kingshuk Bhattacharjee, Nagendra Kumar Singh, Arvind Gupta, Arvind Sharma

    Izdano 2021
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  2. 2
    Humoral antibody kinetics with ChAdOx1-nCOV (Covishield™) and BBV-152 (Covaxin™) vaccine among Indian Healthcare workers: A 6-month longitudinal cross-sectional Coronavirus Vaccine-induced antibody titre (COVAT) study

    Humoral antibody kinetics with ChAdOx1-nCOV (Covishield™) and BBV-152 (Covaxin™) vaccine among Indian Healthcare workers: A 6-month longitudinal cross-sectional Coronavirus Vaccine... od Awadhesh Kumar Singh, Sanjeev Phatak, Ritu Singh, Kingshuk Bhattacharjee, Nagendra Kumar Singh, Arvind Gupta, Arvind Sharma

    Izdano 2022
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  3. 3
    A Multicenter, Retrospective Study to Evaluate the Effectiveness and Safety of Imeglimin in Patients with Type 2 Diabetes Mellitus in a Real-World Clinical Setting (INDI-TIMES Study)

    A Multicenter, Retrospective Study to Evaluate the Effectiveness and Safety of Imeglimin in Patients with Type 2 Diabetes Mellitus in a Real-World Clinical Setting (INDI-TIMES Stud... od Shehla Shaikh, Surendra K. Sharma, Sanjeev Phatak, Arthur Asirvatham, Supratik Bhattacharyya, Vinay Kumar Dhandhania, Sameer Muchhala, Niddhi Baxi

    Izdano 2025
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  4. 4
    Management of metabolic dysfunction–associated steatotic liver disease (<scp>MASLD</scp>)—An expert consensus statement from Indian diabetologists' perspective

    Management of metabolic dysfunction–associated steatotic liver disease (<scp>MASLD</scp>)—An expert consensus statement from Indian diabetologists' perspective od A Amir Zargar, Anil Bhansali, Anirban Majumder, Anuj Maheshwari, Arpandev Bhattacharyya, Arundhati Dasgupta, Banshi Saboo, Bipin Sethi, Debmalya Sanyal, Krishna Seshadri, Neeta Rohit Deshpande, Nitin Kapoor, Om Lakhani, Pradeep Talwalkar, Pramila Kalra, Ravi Mehrotra, Rakesh Sahay, Rishi Shukla, S. Kant, Sambit Das, Sanjay Agarwal, Sanjeev Phatak, G. Shanmugasundar, Shashank Joshi, Shehla Shaikh, Aravind Sosale, Soumik Goswami, Sujoy Ghosh, Vijay Panikar, Viswanathan Mohan

    Izdano 2025
    Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: